Federal contractor · ROCKVILLE, MD

AUTONOMOUS THERAPEUTICS INC

No contract obligations recorded for AUTONOMOUS THERAPEUTICS INC in FY2026. Since FY2018: $7.9M. It also received $2.5M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
JFHPX6TUYMU8
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 504.2KFY2018
  2. 504.2KFY2019
  3. 1.7MFY2020
  4. 4.6MFY2021
  5. 0FY2022
  6. -0FY2023
  7. 0FY2024
  8. 625.9KFY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for AUTONOMOUS THERAPEUTICS INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

AUTONOMOUS THERAPEUTICS INC received $2.5M in federal assistance in FY2026, on 4 actions (0 new awards), −59% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($2.5M).

Assistance · FY2026
$2.5M
New awards
0
Actions
4
Since FY2021
$8.8M

Assistance by fiscal year

  1. 0FY2021
  2. 0FY2022
  3. 273.6KFY2024
  4. 6.1MFY2025
  5. 2.5MFY2026

By type

  1. Grants$2.5M100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$2.5M100%
  2. 93.279 · Drug Use and Addiction Research Programs-$3520.0%

Awarding agencies

  1. National Institutes of Health$2.5M100%
    Department of Health and Human Services

Largest awards

  1. MODULATING STOCHASTIC GENE EXPRESSION FOR CELL-FATE CONTROL AND THERAPEUTICS - PROJECT SUMMARY STOCHASTIC FLUCTUATIONS IN GENE EXPRESSION…$6.4M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Mar 2, 2021 – Nov 30, 2025· R37AI109593
  2. A GENE DRIVE THERAPY FOR HIV: SINGLE-ADMINISTRATION INTERVENTION FOR HIGH-RISK GROUPS$5.7M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· Mar 25, 2021 – Aug 5, 2026· DP1DA051144
  3. TARGETING FEEDBACK CIRCUITRY FOR ANTIVIRAL THERAPY - PROJECT SUMMARY/ABSTRACT THE HUMAN HERPESVIRUS 5 (CYTOMEGALOVIRUS, CMV) INFECTS >50%…$4M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Dec 11, 2023 – Dec 10, 2025· R01AI180651
  4. AT191: AN INHALED & PRECISION RNA THERAPEUTIC WITH PAN-VARIANT SARS-COV-2 EFFICACY - PROJECT SUMMARY/ABSTRACT THIS PHASE II SBIR WILL…$2M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Sep 10, 2025 – Aug 14, 2026· R44AI186871

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

By fiscal year

  • FY2022: $352K paid out · $0 received
  • FY2024: $132K paid out · $0 received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

1 company · $484K reported

  1. BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE$484K
    DUARTE, CA · 3 subawards

Primes that pay it

No prime reported paying it.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. NOUR LLC$666.4K
    WILMETTE, IL · 100% of this company's obligations are in markets they both serveNavy · Scientific research and development services
  2. FALKONRY INC.$700K−60% in FY2026
    CUPERTINO, CA · 100% of this company's obligations are in markets they both serveNavy · Scientific research and development services
  3. FREE FORM FIBERS L.L.C.$799.5K−100% in FY2026
    SARATOGA SPRINGS, NY · 100% of this company's obligations are in markets they both serveNavy · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.